Membership

Categories

View All
Autoimmune Diseases Brain Health Cardiovascular Health Metals Microbes Women’s Health

Conditions

View All
Alzheimer’s Dementia Anemia Autism spectrum disorder (ASD) Bacterial Vaginosis Breast Cancer Chronic Kidney Disease (CKD) Chronic Pelvic Pain (CPP) Crohn’s Disease Diabetes Type I End-Stage Renal Disease (ESRD) Endometriosis Erectile Dysfunction Female Infertility Graves’ Disease (GD) Hashimoto’s Thyroiditis

Definitions

View All
Aflatoxin Amsel’s Criteria Autoantibodies Blood-Brain Barrier (BBB) Bradford Hill Criteria Calprotectin Chelation Coelomic Metaplasia Theory Colibactin Drug Repurposing  EDTA Endometriomas Environmental Theory of Endometriosis Estrobolome Estrogen

Guides & Resources

View All
Endometriosis Guide Microbiome Diet for Endometriosis

Interventions

View All
Boric Acid Cholestyramine Clindamycin Clinoptilolite Zeolite Dimethylglyoxime (DMG) Hyperbaric Oxygen Therapy (HBOT) Lactoferrin Lactulose Low‑Nickel Diet (LNiD) Lugdunin Metformin Metronidazole Phage Therapy Photobiomodulation Probiotics

Supplements

View All
Essential Oils Flavones and Flavonols Guar Gum Pueraria Flower Extract (PFE)

Microbes

View All
E. coli Nissle 1917 Escherichia coli (E. coli) H pylori Microsporum canis (M. canis) Pseudomonas aeruginosa Staphylococcus aureus (S. Aureus) Streptococcus agalactiae (GBS) Streptococcus spp. Ureaplasma urealyticum (U. urealyticum)

Metals

View All
Arsenic (As) Cadmium (Cd) Copper (Cu) Gallium Iron (Fe) Lead (Pb) Mercury Metalloestrogens Nickel Nickel in Escherichia coli: Metabolic and Pathogenic Roles Zinc

Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Fecal calprotectin biomarker in IBD: Clinical Use Increased intestinal absorption of foreign organic compounds in the presence of ethylenediaminetetraacetic acid (EDTA) Cytochrome c-549-an endogenous cofactor of cyclic photophosphorylation in the cyanobacterium Anacystis nidulans? Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children Cadmium transport in blood serum Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease

Posts tagged with "Parkinson's disease" (A-Z)

A C D E F G I M N P R S T
G
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
A
A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
I
Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain
P
Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome
G
Gut microbiota in patients with Parkinson’s disease in southern China
A
Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease
T
The impact of intestinal microbiota on weight loss in Parkinson’s disease patients: a pilot study
R
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
M
Metagenomics of the Gut Microbiome in Parkinson’s Disease: Prodromal Changes
G
Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
C
Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
F
Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson’s disease mouse model via modulating gut microbiota and metabolic homeostasis
A
Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease
N
Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
E
Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson’s disease based on metagenomic sequencing
C
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
A
Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
Analysis of the Gut Microflora in Patients With Parkinson’s Disease
C
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
G
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
S
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
G
Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression
D
Differences in the gut microbiome across typical ageing and in Parkinson’s disease
S
Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
D
Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
A
Altered gut microbiota in Parkinson’s disease patients with motor complications
D
Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study
P
Parkinson’s Disease and the Gut Microbiome in Rural California
I
Integrated Multi-Cohort Analysis of the Parkinson’s Disease Gut Metagenome
M
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson’s Disease
G
Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease
S
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
D
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India
G
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson’s Disease
C
Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China
T
The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson’s disease
The link between increased Desulfovibrio and disease severity in Parkinson’s disease
A
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
P
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
E
Evaluation of fecal microbiota transplantation in Parkinson’s disease patients with constipation
A
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
D
Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease
A
Altered gut microbiota in patients with idiopathic Parkinson’s disease: an age-sex matched case-control study
M
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
E
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
C
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
F
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
M
Metagenome-assembled microbial genomes from Parkinson’s disease fecal samples
Microbial Metallomics Theory of Parkinson’s Disease: A Unified Framework
More than constipation – bowel symptoms in Parkinson’s disease and their connection to gut microbiota
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Yes, I want to help shape the future of microbiome medicine.